Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Impact of saline loading at cardiac catheterization on the classification and management of patients evaluated for pulmonary hypertension.

Moghaddam N, Swiston JR, Weatherald J, Mielniczuk L, Kapasi A, Hambly N, Langleben D, Brunner NW.

Int J Cardiol. 2019 Nov 14. pii: S0167-5273(19)33892-6. doi: 10.1016/j.ijcard.2019.11.104. [Epub ahead of print]

PMID:
31784045
2.

Lessons from lung transplantation: Cause for redefining the pathophysiology of pulmonary hypertension in gaucher disease.

Goobie GC, Sirrs SM, Yee J, English JC, Bergeron C, Nador R, Swiston JR, Mistry PK, Paquin W, Levy RD.

Respir Med Case Rep. 2019 Jun 29;28:100893. doi: 10.1016/j.rmcr.2019.100893. eCollection 2019.

3.

Clinical and hemodynamic factors in predicting response to fluid challenge during right heart catheterization.

Moghaddam N, Swiston JR, Levy RD, Lee L, Huckell VF, Brunner NW.

Pulm Circ. 2019 Jan-Mar;9(1):2045894018819803. doi: 10.1177/2045894018819803. Epub 2018 Dec 3.

4.

Comparison of thermodilution and indirect Fick cardiac outputs in pulmonary hypertension.

Alkhodair A, Tsang MYC, Cairns JA, Swiston JR, Levy RD, Lee L, Huckell VF, Brunner NW.

Int J Cardiol. 2018 May 1;258:228-231. doi: 10.1016/j.ijcard.2018.01.076. Epub 2018 Feb 2.

PMID:
29426632
5.

Validity of algorithm for estimating left sided filling pressures on echocardiography in a population referred for pulmonary arterial hypertension.

Leung EC, Swiston JR, AlAhmari L, AlAhmari T, Huckell VF, Brunner NW.

Pulm Circ. 2017 Oct-Dec;7(4):2045893217740471. doi: 10.1177/2045893217740471. Epub 2017 Oct 17.

6.

Clinical manifestations and diagnostic methods in pulmonary angiosarcoma: protocol for a scoping review.

Lim R, Harper L, Swiston J.

Syst Rev. 2017 Jul 10;6(1):136. doi: 10.1186/s13643-017-0531-6.

7.

Drugs for Pulmonary Arterial Hypertension: Comparative Efficacy, Safety, and Cost-Effectiveness [Internet].

Tran K, Coyle K, Jabr MF, Coyle D, Boucher M, Mielniczuk L, Swiston JR, Rabb D, Cimon K, Blouin J, Innes M.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Mar.

8.

Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study.

Coyle K, Coyle D, Blouin J, Lee K, Jabr MF, Tran K, Mielniczuk L, Swiston J, Innes M.

Pharmacoeconomics. 2016 May;34(5):509-20. doi: 10.1007/s40273-015-0366-8.

9.

Prognostic utility of right atrial emptying fractions in pulmonary arterial hypertension.

Brunner NW, Haddad F, Kobayashi Y, Hsi A, Swiston JR, Gin KG, Zamanian RT.

Pulm Circ. 2015 Sep;5(3):473-80. doi: 10.1086/682218.

10.

A Clinical Classification Scheme for Tracheobronchomegaly (Mounier-Kuhn Syndrome).

Payandeh J, McGillivray B, McCauley G, Wilcox P, Swiston JR, Lehman A.

Lung. 2015 Oct;193(5):815-22. doi: 10.1007/s00408-015-9757-z. Epub 2015 Jul 19. Review.

PMID:
26189148
11.

Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Mielniczuk LM, Swiston JR, Mehta S.

Can J Cardiol. 2014 Oct;30(10):1233-40. doi: 10.1016/j.cjca.2014.04.014. Epub 2014 Apr 18. Review.

PMID:
25154043
12.

Pregnancy among women with pulmonary arterial hypertension: a changing landscape?

Tabarsi N, Levy R, Rychel V, Kiess M, Swiston J, Oakes J, Grewal J.

Int J Cardiol. 2014 Dec 15;177(2):490-1. doi: 10.1016/j.ijcard.2014.08.059. Epub 2014 Aug 15. No abstract available.

PMID:
25150484
13.

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Medical and surgical management for pulmonary arterial hypertension.

Idrees MM, Swiston J, Nizami I, Al Dalaan A, Levy RD.

Ann Thorac Med. 2014 Jul;9(Suppl 1):S79-91. doi: 10.4103/1817-1737.134043.

14.

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: General management for pulmonary hypertension.

Idrees MM, Swiston J, Levy RD.

Ann Thorac Med. 2014 Jul;9(Suppl 1):S74-8. doi: 10.4103/1817-1737.134041.

15.

Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates.

Idrees MM, Saleemi S, Azem MA, Aldammas S, Alhazmi M, Khan J, Gari A, Aldabbagh M, Sakkijha H, Aldalaan A, Alnajashi K, Alhabeeb W, Nizami I, Kouatli A, Chehab M, Tamimi O, Banjar H, Kashour T, Lopes A, Minai O, Hassoun P, Pasha Q, Mayer E, Butrous G, Bhagavathula S, Ghio S, Swiston J, Boueiz A, Tonelli A, Levy RD, Hoeper M, Levy RD.

Ann Thorac Med. 2014 Jul;9(Suppl 1):S1-S15. doi: 10.4103/1817-1737.134006.

16.

Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis.

Janda S, Swiston J.

Chest. 2012 Aug;142(2):401-411. doi: 10.1378/chest.11-3071. Review.

PMID:
22459772
17.
19.

Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis.

Janda S, Shahidi N, Gin K, Swiston J.

Heart. 2011 Apr;97(8):612-22. doi: 10.1136/hrt.2010.212084. Epub 2011 Feb 25. Review. Erratum in: Heart. 2011 Jul;97(13):1112.

PMID:
21357375
20.

Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.

Mehta S, Helmersen D, Provencher S, Hirani N, Rubens FD, De Perrot M, Blostein M, Boutet K, Chandy G, Dennie C, Granton J, Hernandez P, Hirsch AM, Laframboise K, Levy RD, Lien D, Martel S, Shoemaker G, Swiston J, Weinkauf J; Canadian Thoracic Society Pulmonary Vascular Disease - CTEPH CPG Development Committee; Canadian Thoracic Society Canadian Respiratory Guidelines Committee.

Can Respir J. 2010 Nov-Dec;17(6):301-34.

21.
22.

Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature.

Swiston JR, Johnson SR, Granton JT.

Respir Med. 2010 Nov;104(11):1588-607. doi: 10.1016/j.rmed.2010.08.003. Review.

23.

The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis.

Janda S, Young A, Fitzgerald JM, Etminan M, Swiston J.

J Crit Care. 2010 Dec;25(4):656.e7-22. doi: 10.1016/j.jcrc.2010.02.013. Epub 2010 Apr 22. Review.

PMID:
20413251
24.

HIV and pulmonary arterial hypertension: a systematic review.

Janda S, Quon BS, Swiston J.

HIV Med. 2010 Nov;11(10):620-34. doi: 10.1111/j.1468-1293.2010.00829.x. Review.

25.

Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis.

Ryerson CJ, Nayar S, Swiston JR, Sin DD.

Respir Res. 2010 Jan 29;11:12. doi: 10.1186/1465-9921-11-12. Review.

26.

Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization.

Bahadori K, FitzGerald JM, Levy RD, Fera T, Swiston J.

Can Respir J. 2009 Jul-Aug;16(4):e43-9.

27.

Economic burden of asthma: a systematic review.

Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM.

BMC Pulm Med. 2009 May 19;9:24. doi: 10.1186/1471-2466-9-24. Review.

28.

Statins in COPD: a systematic review.

Janda S, Park K, FitzGerald JM, Etminan M, Swiston J.

Chest. 2009 Sep;136(3):734-743. doi: 10.1378/chest.09-0194. Epub 2009 Apr 17. Review.

PMID:
19376844
29.

Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension.

McGowan CL, Swiston JS, Notarius CF, Mak S, Morris BL, Picton PE, Granton JT, Floras JS.

Heart. 2009 May;95(9):754-8. doi: 10.1136/hrt.2008.157115. Epub 2009 Jan 16.

PMID:
19151012
30.

Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension.

Johnson SR, Swiston JR, Granton JT.

J Rheumatol. 2008 Aug;35(8):1584-90. Epub 2008 Jul 1. Review. Erratum in: J Rheumatol. 2009 Mar;36(3):661. Swinton, John R [corrected to Swiston, John R].

PMID:
18597400
31.

Wood smoke exposure induces a pulmonary and systemic inflammatory response in firefighters.

Swiston JR, Davidson W, Attridge S, Li GT, Brauer M, van Eeden SF.

Eur Respir J. 2008 Jul;32(1):129-38. doi: 10.1183/09031936.00097707. Epub 2008 Feb 6.

32.

Isolated native tricuspid valve endocarditis caused by viridans streptococcus.

Swiston J, Shafran SD, Kassam N.

Can J Infect Dis. 2001 Sep;12(5):305-7.

33.

Improved survival of biolistically transfected mouse islet allografts expressing CTLA4-Ig or soluble Fas ligand.

Gainer AL, Suarez-Pinzon WL, Min WP, Swiston JR, Hancock-Friesen C, Korbutt GS, Rajotte RV, Warnock GL, Elliott JF.

Transplantation. 1998 Jul 27;66(2):194-9.

PMID:
9701263
34.
35.

Differential expression of CAP and CAP2 in adult rat tissues.

Swiston J, Hubberstey A, Yu G, Young D.

Gene. 1995 Nov 20;165(2):273-7.

PMID:
8522189
36.

Supplemental Content

Loading ...
Support Center